Anna Falk
Principal Researcher | Docent
E-mail: anna.falk@ki.se
Telephone: +46852482897
Visiting address: Solnavägen 9 - kvarter D7, 17165 Solna
Postal address: C4 Neurovetenskap, C4 Forskning Falk, 171 77 Stockholm
About me
- iPS cell models of human brain development in health and disease.
I started the Falk lab in 2012 and have since educated four PhD students to
finalize their PhD degrees with me as their main supervisor. The Falk lab has
also had numerous amounts of postdocs and bachelor and master students
through the years.
I did my PhD at Karolinska Institutet with Professor Jonas Frisén and
continued with a postdoc in the lab of Professor Austin Smith at the
University of Cambridge, UK.
A couple of years ago I did a sabbatical in the lab of Professor Rusty Gage
at the Salk Institute in San Diego, US.
I really love my job and I do research since it is rewarding to go from
ideas, hypothesis, project plan, experimental design, experiments, analysis,
validating, summarizing, writing a story about novel findings to
understanding disorders and with the potential to improve human health.
Selected to the career development programme for young researcher as one of
ten young research leaders in Sweden across all sciences. This grant (6 MSEK
from the Swedish Foundation for Strategic Research SSF) provides support for
successful young scientists to build up their own independent careers.
Research grant from SciLifeLab/AZ to model human neurological disorders and
to use the national core facilities at SciLifeLab (20 MSEK)
I have a Master of Science in Molecular Biology from Umeå University
PhD in Molecular Biology from Karolinska Institutet about neural stem cells
Docent (Associate Professor) in Stem cell Biology
Research
- The Falk lab is deriving cellular models of neural stem cells, neurons and
glia from iPS cells to study proliferation, differentiation, migration, fate
choosing mechanisms using assays of transcriptome of bulk or single cells.
Our studies concentrate mostly on early neurogenesis and modeling of
neurodevelopment and neuropsychiatric disorders. We have revealed
neurite outgrowth phenotypes in iPS cell models of Lissencephaly and other
neurodevelopment disorders. We have on the single cells level investigated
how iPS cell derived neural stem cells are choosing fate between neurons and
glia and how that mechanisms is skewed in iPS cells from individuals
diagnosed with autism and schizophrenia.
The Falk lab is also driving translational projects investigating the
regenerative potential of iPS cell derived neural cells in preclinical models
with the aim to create ATMPs to take iPS derived cell to clinic. We have
derived one of few clinical compliant GMP iPS cell lines that we have banked
in a master bank and we are now investigating the route forward to clinic.
The iPS Core facility at Karolinska Institutet is providing services in the
area of fibroblast establishment, reprogramming, iPS cell culture, neural
induction, neural stem cells, neurons, astrocytes, neural crest and soon also
whole brain organoids. The services are custom-tailored spanning from
providing vials of frozen cells, to hand-on training, to customers monthly
subscribing for mature human neurons. The iPS Core is the Swedish "Cell
vending machine". Get your cell model of interest arrayed in the format you
need. https://ipscore.se [1]
*A few recent publications*
Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR
Axis that Promotes Malignancy. [2]
Čančer M, Hutter S, Holmberg KO, Rosén G, Sundström A, Tailor J,
Bergström T, Garancher A, Essand M, Wechsler-Reya RJ, Falk A, Weishaupt H,
Swartling FJ
/Cell Stem Cell 2019 Dec;25(6):855-870.e11/
Single cell analysis of autism patient with bi-allelic NRXN1-alpha deletion
reveals skewed fate choice in neural progenitors and impaired neuronal
functionality. [3]
Lam M, Moslem M, Bryois J, Pronk RJ, Uhlin E, Ellström ID, Laan L, Olive J,
Morse R, Rönnholm H, Louhivuori L, Korol SV, Dahl N, Uhlén P, Anderlid BM,
Kele M, Sullivan PF, Falk A
/Exp Cell Res 2019 10;383(1):111469/
Human iPS-Derived Astroglia from a Stable Neural Precursor State Show
Improved Functionality Compared with Conventional Astrocytic Models. [4]
Lundin A, Delsing L, Clausen M, Ricchiuto P, Sanchez J, Sabirsh A, Ding M,
Synnergren J, Zetterberg H, Brolén G, Hicks R, Herland A, Falk A
/Stem Cell Reports 2018 03;10(3):1030-1045/
An in vitro model of lissencephaly: expanding the role of DCX during
neurogenesis. [5]
Shahsavani M, Pronk RJ, Falk R, Lam M, Moslem M, Linker SB, Salma J, Day K,
Schuster J, Anderlid BM, Dahl N, Gage FH, Falk A
/Mol Psychiatry 2018 07;23(7):1674-1684/
Derivation of human iPS cell lines from monozygotic twins in defined and xeno
free conditions. [6]
Uhlin E, Rönnholm H, Day K, Kele M, Tammimies K, Bölte S, Falk A
/Stem Cell Res 2017 01;18():22-25/
[1] https://ipscore.se
[2] https://www.ncbi.nlm.nih.gov/pubmed/31786016
[3] https://www.ncbi.nlm.nih.gov/pubmed/31302032
[4] https://www.ncbi.nlm.nih.gov/pubmed/29456185
[5] https://www.ncbi.nlm.nih.gov/pubmed/28924182
[6] https://www.ncbi.nlm.nih.gov/pubmed/28395796
Teaching
- I have been the organizer of a master and PhD courses about cellular
reprogramming in addition to hand-on course and train for culturing stem
cells.
I am continuously lecturing at Karolinska Institutet and other Universities
and supervising bachelor, master and PhD students.
Articles
- Article: COMMUNICATIONS BIOLOGY. 2025;8(1):255Eidhof I; Ulfenborg B; Kele M; Shahsavani M; Winn D; Uhlen P; Falk A
- Article: BRAIN BEHAVIOR AND IMMUNITY. 2025;123:28-42Bose R; Posada-Perez M; Karvela E; Skandik M; Keane L; Falk A; Spulber S; Joseph B; Ceccatelli S
- Article: NEURO-ONCOLOGY. 2024;26(9):1685-1699Zhou L; van Bree N; Boutin L; Ryu J; Moussaud S; Liu M; Otrocka M; Olsson M; Falk A; Wilhelm M
- Article: ADVANCED SCIENCE. 2024;11(25):e2401859Jain S; Voulgaris D; Thongkorn S; Hesen R; Hagg A; Moslem M; Falk A; Herland A
- Article: FRONTIERS IN PHARMACOLOGY. 2024;15:1390058Winn D; Uhlin E; Kele M; Eidhof I; Falk A
- Article: BIOLOGY OPEN. 2023;12(10):bio060113Mastropasqua F; Oksanen M; Soldini C; Alatar S; Arora A; Ballarino R; Molinari M; Agostini F; Poulet A; Watts M; Rabkina I; Becker M; Li D; Anderlid B-M; Isaksson J; Remnelius KL; Moslem M; Jacob Y; Falk A; Crosetto N; Bienko M; Santini E; Borgkvist A; Bo''lte S; Tammimies K
- Article: SCIENTIFIC REPORTS. 2023;13(1):10519Arora A; Becker M; Marques C; Oksanen M; Li D; Mastropasqua F; Watts ME; Arora M; Falk A; Daub CO; Lanekoff I; Tammimies K
- Journal article: NEUROSCIENCE APPLIED. 2023;2:101125Polit LD; Eidhof I; Mcneill RV; Warre-Cornish KM; Ohki CMY; Walter NM; Sala C; Verpelli C; Radtke F; Galderisi S; Mucci A; Collo G; Edenhofer F; Castren ML; Rethelyi JM; Ejlersen M; Hohmann SS; Ilieva MS; Lukjanska R; Matuleviciute R; Michel TM; de Vrij FMS; Kushner SA; Lendemeijer B; Kittel-Schneider S; Ziegler GC; Gruber-Schoffnegger D; Pasterkamp RJ; Kasri A; Potier M-C; Knoblich JA; Bruestle O; Peitz M; Pich EM; Harwood AJ; Abranches E; Falk A; Vernon AC; Gruenblatt E; Srivastava DP
- Article: HUMAN MUTATION. 2022;43(11):1567-1575Eisfeldt J; Rezayee F; Pettersson M; Lagerstedt K; Malmgren H; Falk A; Grigelioniene G; Lindstrand A
- Article: STEM CELL REPORTS. 2022;17(10):2203-2219Drouin-Ouellet J; Legault EM; Nilsson F; Pircs K; Bouquety J; Petit F; Shrigley S; Birtele M; Pereira M; Storm P; Sharma Y; Bruzelius A; Vuono R; Kele M; Stoker TB; Ottosson DR; Falk A; Jakobsson J; Barker RA; Parmar M
- Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022;23(16):9392Eisfeldt J; Schuy J; Stattin E-L; Kvarnung M; Falk A; Feuk L; Lindstrand A
- Article: ENVIRONMENTAL TOXICOLOGY. 2022;37(8):2044-2057Reis L; Raciti M; Rodriguez PG; Joseph B; Al Rayyes I; Uhlen P; Falk A; Lima STDC; Ceccatelli S
- Article: EBIOMEDICINE. 2022;77:103882Xu T; Li X; Guo Y; Uhlin E; Holmberg L; Mitra S; Winn D; Falk A; Sundstrom E
- Article: FRONTIERS IN GENETICS. 2022;12:803683Schuy J; Eisfeldt J; Pettersson M; Shahrokhshahi N; Moslem M; Nilsson D; Dahl N; Shahsavani M; Falk A; Lindstrand A
- Article: STAR PROTOCOLS. 2021;2(2):100528Calvo-Garrido J; Winn D; Maffezzini C; Wedell A; Freyer C; Falk A; Wredenberg A
- Article: JOURNAL OF NEUROINFLAMMATION. 2021;18(1):124Rostami J; Mothes T; Kolahdouzan M; Eriksson O; Moslem M; Bergstrom J; Ingelsson M; O'Callaghan P; Healy LM; Falk A; Erlandsson A
- Article: NEUROTHERAPEUTICS. 2021;18(2):1257-1272Xu N; Xu T; Mirasol R; Holmberg L; Vincent PH; Li X; Falk A; Benedikz E; Rotstein E; Seiger A; Akesson E; Falci S; Sundstrom E
- Article: VIRUSES-BASEL. 2020;13(1):E37-37Pettke A; Tampere M; Pronk R; Wallner O; Falk A; Warpman Berglund U; Helleday T; Mirazimi A; Puumalainen M-R
- Article: BIOMEDICINE & PHARMACOTHERAPY. 2020;131:110788Rostami J; Jantti M; Cui H; Rinne MK; Kukkonen JP; Falk A; Erlandsson A; Myohanen T
- Article: TRANSLATIONAL PSYCHIATRY. 2020;10(1):312Becker M; Mastropasqua F; Reising JP; Maier S; Ho M-L; Rabkina I; Li D; Neufeld J; Ballenberger L; Myers L; Moritz V; Kele M; Wincent J; Willfors C; Sitnikov R; Herlenius E; Anderlid B-M; Falk A; Bolte S; Tammimies K
- Article: NATURE BIOMEDICAL ENGINEERING. 2020;4(9):875-888Tanaka N; Kanatani S; Kaczynska D; Fukumoto K; Louhivuori L; Mizutani T; Kopper O; Kronqvist P; Robertson S; Lindh C; Kis L; Pronk R; Niwa N; Matsumoto K; Oya M; Miyakawa A; Falk A; Hartman J; Sahlgren C; Clevers H; Uhlen P
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(33):20127-20138Susanto E; Navarro AM; Zhou L; Sundstrom A; van Bree N; Stantic M; Moslem M; Tailor J; Rietdijk J; Zubillaga V; Huebner J-M; Weishaupt H; Wolfsberger J; Alafuzoff I; Nordgren A; Magnaldo T; Siesjo P; Johnsen JI; Kool M; Tammimies K; Darabi A; Swartling FJ; Falk A; Wilhelm M
- Article: MOLECULAR NEUROBIOLOGY. 2020;57(7):2944-2958Bieder A; Yoshihara M; Katayama S; Krjutskov K; Falk A; Kere J; Tapia-Paez I
- Article: BIOMATERIALS SCIENCE. 2020;8(9):2514-2525Astrand C; Chotteau V; Falk A; Hedhammar M
- Article: ADVANCED BIOLOGY. 2020;4(5):e1900226Lundin A; Ricchiuto P; Clausen M; Hicks R; Falk A; Herland A
- Article: NATURE COMMUNICATIONS. 2020;11(1):1609Reyes AP; Petrus-Reurer S; Sanchez SP; Kumar P; Douagi I; Bartuma H; Aronsson M; Westman S; Lardner E; Andre H; Falk A; Nandrot EF; Kvanta A; Lanner F
- Article: CELL DEATH & DISEASE. 2020;11(1):52Navarro AM; Pronk RJ; van der Geest AT; Oliynyk G; Nordgren A; Arsenian-Henriksson M; Falk A; Wilhelm M
- Article: CLINICAL EPIGENETICS. 2020;12(1):9Laan L; Klar J; Sobol M; Hoeber J; Shahsavani M; Kele M; Fatima A; Zakaria M; Anneren G; Falk A; Schuster J; Dahl N
- Article: CELL STEM CELL. 2019;25(6):855-870.e11Cancer M; Hutter S; Holmberg KO; Rosen G; Sundstrom A; Tailor J; Bergstrom T; Garancher A; Essand M; Wechsler-Reya RJ; Falk A; Weishaupt H; Swartling FJ
- Article: GENES TO CELLS. 2019;24(12):836-847Lam M; Sanosaka T; Lundin A; Imaizumi K; Etal D; Karlsson FH; Clausen M; Cairns J; Hicks R; Kohyama J; Kele M; Okano H; Falk A
- Article: MOLECULAR NEUROBIOLOGY. 2019;56(10):7113-7127Sobol M; Klar J; Laan L; Shahsavani M; Schuster J; Anneren G; Konzer A; Mi J; Bergquist J; Nordlund J; Hoeber J; Huss M; Falk A; Dahl N
- Article: EXPERIMENTAL CELL RESEARCH. 2019;383(1):111469Lam M; Moslem M; Bryois J; Pronk RJ; Uhlin E; Ellstrom ID; Laan L; Olive J; Morse R; Ronnholm H; Louhivuori L; Korol SV; Dahl N; Uhlen P; Anderlid B-M; Kele M; Sullivan PF; Falk A
- Article: FRONTIERS IN GENETICS. 2019;10:896Kvarnung M; Shahsavani M; Taylan F; Moslem M; Breeuwsma N; Laan L; Schuster J; Jin Z; Nilsson D; Lieden A; Anderlid B-M; Nordenskjold M; Lundberg ES; Birnir B; Dahl N; Nordgren A; Lindstrand A; Falk A
- Article: FRONTIERS IN GENETICS. 2019;10:593Raciti M; Selma J; Spulber S; Gaudenzi G; Khalajzeyqami Z; Conti M; Anderlid B-M; Falk A; Hermanson O; Ceccatelli S
- Article: MOLECULAR GENETICS & GENOMIC MEDICINE. 2019;7(6):e654Maffezzini C; Laine I; Dallabona C; Clemente P; Calvo-Garrido J; Wibom R; Naess K; Barbaro M; Falk A; Donnini C; Freyer C; Wredenberg A; Wedell A
- Article: JOURNAL OF MOLECULAR CELL BIOLOGY. 2019;11(5):356-370Heras G; Namuduri AV; Traini L; Shevchenko G; Falk A; Lind SB; Jia M; Tian G; Gastaldello S
- Article: STEM CELL REPORTS. 2019;12(4):696-711Calvo-Garrido J; Maffezzini C; Schober FA; Clemente P; Uhlin E; Kele M; Stranneheim H; Lesko N; Bruhn H; Svenningsson P; Falk A; Wedell A; Freyer C; Wredenberg A
- Article: NEUROSCIENCE. 2019;402:78-89Rebellato P; Kaczynska A; Kanatani S; Al Rayyes I; Zhang S; Villaescusa C; Falk A; Arenas E; Hermanson O; Louhivuori L; Uhlen P
- Article: STEM CELL RESEARCH. 2019;34:101356Navarro AM; Day K; Kogner P; Wilhelm M; Falk A
- Article: STEM CELLS. 2018;36(12):1816-1827Delsing L; Donnes P; Sanchez J; Clausen M; Voulgaris D; Falk A; Herland A; Brolen G; Zetterberg H; Hicks R; Synnergren J
- Article: MOLECULAR PSYCHIATRY. 2018;23(7):1674-1684Shahsavani M; Pronk RJ; Falk R; Lam M; Moslem M; Linker SB; Salma J; Day K; Schuster J; Anderlid B-M; Dahl N; Gage FH; Falk A
- Article: STEM CELL REPORTS. 2018;10(3):1030-1045Lundin A; Delsing L; Clausen M; Ricchiuto P; Sanchez J; Sabirsh A; Ding M; Synnergren J; Zetterberg H; Brolen G; Hicks R; Herland A; Falk A
- Article: JOURNAL OF ALZHEIMERS DISEASE. 2018;62(1):175-202Wezyk M; Szybinska A; Wojsiat J; Szczerba M; Day K; Ronnholm H; Kele M; Berdynski M; Peplonska B; Fichna JP; Ilkowski J; Styczynska M; Barczak A; Zboch M; Filipek-Gliszczynska A; Bojakowski K; Skrzypczak M; Ginalski K; Kabza M; Makalowska I; Barcikowska-Kotowicz M; Wojda U; Falk A; Zekanowski C
- Journal article: NEURO-ONCOLOGY. 2017;19(suppl_6):vi255Čančer M; Hutter S; Rosén G; Hellström A-C; Essand M; Huang M; Tailor J; Smith A; Weiss WA; Falk A; Weishaupt H; Swartling F
- Article: SCIENTIFIC REPORTS. 2017;7(1):11458Yu NY; Bieder A; Raman A; Mileti E; Katayama S; Einarsdottir E; Fredholm BB; Falk A; Tapia-Paez I; Daub CO; Kere J
- Journal article: JOVE-JOURNAL OF VISUALIZED EXPERIMENTS. 2017;(125)Uhlin E; Marin Navarro A; Rönnholm H; Day K; Kele M; Falk A
- Article: JOVE-JOURNAL OF VISUALIZED EXPERIMENTS. 2017;(125)Uhlin E; Navarro AM; Ronnholm H; Day K; Kele M; Falk A
- Article: CELL REPORTS. 2017;18(1):1-11Brattas PL; Jonsson ME; Fasching L; Wahlestedt JN; Shahsavani M; Falk R; Falk A; Jern P; Parmar M; Jakobsson J
- Article: STEM CELL RESEARCH. 2017;18:22-25Uhlin E; Ronnholm H; Day K; Kele M; Tammimies K; Bolte S; Falk A
- Article: EMBO JOURNAL. 2016;35(18):1963-1978Villaescusa JC; Li B; Toledo EM; Cervo PRDV; Yang S; Stott SRW; Kaiser K; Islam S; Gyllborg D; Laguna-Goya R; Landreh M; Lonnerberg P; Falk A; Bergman T; Barker RA; Linnarsson S; Selleri L; Arenas E
- Article: NEUROPHARMACOLOGY. 2016;107:422-431Raciti M; Ong J; Weis L; Edoff K; Battagli C; Falk A; Ceccatelli S
- Article: AMERICAN JOURNAL OF STEM CELLS. 2016;5(1):19-28Ali RQ; Blomberg E; Falk A; Ahrlund-Richter L; Ulfendahl M
- Article: BIOMATERIALS. 2014;35(30):8496-8502Spider silk for xeno-free long-term self-renewal and differentiation of human pluripotent stem cellsWu S; Johansson J; Damdimopoulou P; Shahsavani M; Falk A; Hovatta O; Rising A
- Article: TWIN RESEARCH AND HUMAN GENETICS. 2014;17(3):164-176Bölte S; Willfors C; Berggren S; Norberg J; Poltrago L; Mevel K; Coco C; Fransson P; Borg J; Sitnikov R; Toro R; Tammimies K; Anderlid B-M; Nordgren A; Falk A; Meyer U; Kere J; Landén M; Dalman C; Ronald A; Anckarsäter H; Lichtenstein P
- Article: BIOMATERIALS. 2014;35(5):1420-1428Zhang D; Pekkanen-Mattila M; Shahsavani MO; Falk A; Teixeira AI; Herland A
- Article: JOURNAL OF NEUROSCIENCE. 2013;33(30):12407-12422Tailor J; Kittappa R; Leto K; Gates M; Borel M; Paulsen O; Spitzer S; Karadottir RT; Rossi F; Falk A; Smith A
- Article: JOURNAL OF BIOMOLECULAR SCREENING. 2013;18(3):258-268McLaren D; Gorba T; de Rotrou AM; Pillai G; Chappell C; Stacey A; Lingard S; Falk A; Smith A; Koch P; Bruestle O; Vickers R; Tinsley J; Flanders D; Bello P; Craig S
- Article: METHODS. 2012;58(1):69-78Falk R; Falk A; Dyson MR; Melidoni AN; Parthiban K; Young JL; Roake W; McCafferty J
- Article: STEM CELLS. 2012;30(6):1163-1173Fujimoto Y; Abematsu M; Falk A; Tsujimura K; Sanosaka T; Juliandi B; Semi K; Namihira M; Komiya S; Smith A; Nakashima K
- Article: PLOS ONE. 2012;7(1):e29597Falk A; Koch P; Kesavan J; Takashima Y; Ladewig J; Alexander M; Wiskow O; Tailor J; Trotter M; Pollard S; Smith A; Bruestle O
- Article: NEUROCHEMISTRY INTERNATIONAL. 2011;59(3):432-444Hook L; Vives J; Fulton N; Leveridge M; Lingard S; Bootman MD; Falk A; Pollard SM; Allsopp TE; Dalma-Weiszhausz D; Tsukamoto A; Uchida N; Gorba T
- Article: BIOCHEMICAL SOCIETY TRANSACTIONS. 2010;38(4):1067-1071Danovi D; Falk A; Humphreys P; Vickers R; Tinsley J; Smith AG; Pollard SM
- Article: PLOS ONE. 2009;4(5):e5498Sun Y; Kong W; Falk A; Hu J; Zhou L; Pollard S; Smith A
- Article: MOLECULAR AND CELLULAR NEUROSCIENCE. 2008;38(2):245-258Sun Y; Pollard S; Conti L; Toselli M; Biella G; Parkin G; Willatt L; Falk A; Cattaneo E; Smith A
- Article: STEM CELLS. 2007;25(6):1539-1545Falk A; Karlsson TE; Kurdija S; Frisen J; Zupicich J
- Article: DEVELOPMENT. 2003;130(24):6089-6099Dahlqvist C; Blokzijl A; Chapman G; Falk A; Dannaeus K; Ibâñez CF; Lendahl U
- Article: JOURNAL OF CELL BIOLOGY. 2003;163(4):723-728Blokzijl A; Dahlqvist C; Reissmann E; Falk A; Moliner A; Lendahl U; Ibáñez CF
- Article: JOURNAL OF NEUROSCIENCE RESEARCH. 2002;69(6):757-762Falk A; Frisén J
- Article: EXPERIMENTAL CELL RESEARCH. 2002;279(1):34-39Falk A; Holmström N; Carlén M; Cassidy R; Lundberg C; Frisén J
- Show more
All other publications
- Preprint: BIORXIV. 2025Kang W; Yip H; Verron Q; Bouwman BAM; Li-Wang X; Yaghi AA; Murata M; Stout M; Salviati L; Shu X; Yasuzawa K; Gaviraghi M; Pracana R; Lord J; Ballarino R; Falk A; Shin JW; Kasukawa T; Yip CW; Kato M; Takahashi H; Crosetto N; Carninci P; Bienko M
- Editorial comment: CELL STEM CELL. 2025;32(3):341-342Parmar M; Falk A
- Preprint: BIORXIV. 2025Martinez-Curiel R; Rincón-Cerrada P; Al Khani A-M; Tsupykov O; Martín-Hernández D; Monni E; Savchenko E; Rodríguez LR; Kidnapillai S; Bruzelius A; Hidalgo I; Canals I; Bengzon J; Skibo G; Ottosson DR; Falk A; Ahlenius H; Lindvall O; Kokaia Z; Palma-Tortosa S
- Preprint: BIORXIV. 2024Zhou L; van Bree N; Boutin L; Moussaud S; Otrocka M; Falk A; Wilhelm M
- Editorial comment: CELL STEM CELL. 2024;31(2):152-154Eidhof I; Twohig D; Falk A
- Preprint: BIORXIV. 2022Mastropasqua F; Oksanen M; Soldini C; Alatar S; Arora A; Ballarino R; Molinari M; Agostini F; Poulet A; Watts M; Rabkina I; Becker M; Li D; Anderlid B-M; Isaksson J; Remnelius KL; Moslem M; Jacob Y; Falk A; Crosetto N; Bienko M; Santini E; Borgkvist A; Bölte S; Tammimies K
- Preprint: BIORXIV. 2022Arora A; Becker M; Marques C; Oksanen M; Li D; Mastropasqua F; Watts ME; Arora M; Falk A; Daub CO; Lanekoff I; Tammimies K
- Conference publication: GLIA. 2021;69:E186Konstantinidis E; Beretta C; Falk A; Erlandsson A
- Corrigendum: BIOMEDICINE & PHARMACOTHERAPY. 2021;133:111019Rostami J; Jantti M; Cui H; Rinne MK; Kukkonen JP; Falk A; Erlandsson A; Myohanen T
- Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2020;28(SUPPL 1):588Schuy J; Eisfeldt J; Pettersson M; Shahrokhshahi N; Shahsavani M; Nilsson D; Falk A; Lindstrand A
- Review: MOLECULAR AND CELLULAR NEUROSCIENCE. 2020;107:103533Delsing L; Herland A; Falk A; Hicks R; Synnergren J; Zetterberg H
- Corrigendum: NATURE COMMUNICATIONS. 2020;11(1):3504Reyes AP; Petrus-Reurer S; Sanchez SP; Kumar P; Douagi I; Bartuma H; Aronsson M; Westman S; Lardner E; Andre H; Falk A; Nandrot EF; Kvanta A; Lanner F
- Review: MOLECULAR AUTISM. 2020;11(1):42Drakulic D; Djurovic S; Syed YA; Trattaro S; Caporale N; Falk A; Ofir R; Heine VM; Chawner SJRA; Rodriguez-Moreno A; van den Bree MBM; Testa G; Petrakis S; Harwood AJ
- Corrigendum: NATURE COMMUNICATIONS. 2020;11(1):2346Reyes AP; Petrus-Reurer S; Sanchez SP; Kumar P; Douagi I; Bartuma H; Aronsson M; Westman S; Lardner E; Andre H; Falk A; Nandrot EF; Kvanta A; Lanner F
- Review: OXIDATIVE MEDICINE AND CELLULAR LONGEVITY. 2019;2019:2149812-10Kieroń M; Żekanowski C; Falk A; Wężyk M
- Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2019;27:1143Kvarnung M; Shahsavani M; Taylan F; Breeuwsma N; Laan L; Schuster J; Jin Z; Nilsson D; Lieden A; Anderlid B; Nordenskjold M; Lundberg ES; Birnir B; Dahl N; Nordgren A; Lindstrand A; Falk A
- Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2019;27:1437Mastropasqua F; Rabkina I; Becker M; Anderlid B; Bolte S; Falk A; Tammimies K
- Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2019;27:1501-1502Laan L; Klar J; Sobol M; Hoeber J; Zakaria M; Anneren G; Falk A; Schuster J; Dahl N
- Review: SCHIZOPHRENIA RESEARCH. 2019;210:3-12Moslem M; Olive J; Falk A
- Editorial comment: STEM CELL REPORTS. 2018;11(4):847-849Lundin A; Falk A
- Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2018;26:366Klar J; Schuster J; Laan L; Sobol M; Lorenzo LP; Nordlund J; Shahsavani M; Falk A; Dahl N
- Review: CELL DEATH DISCOVERY. 2018;4:7Navarro AM; Susanto E; Falk A; Wilhelm M
- Editorial comment: STEM CELL RESEARCH. 2016;17(3):474-478Kele M; Day K; Ronnholm H; Schuster J; Dahl N; Falk A
- Corrigendum: MOLECULAR PSYCHIATRY. 2016;21(9):1321Falk A; Heine VM; Harwood AJ; Sullivan PF; Peitz M; Brüstle O; Shen S; Sun Y-M; Glover JC; Posthuma D; Djurovic S
- Review: MOLECULAR PSYCHIATRY. 2016;21(9):1167-1179Falk A; Heine VM; Harwood AJ; Sullivan PF; Peitz M; Bruestle O; Shen S; Sun Y-M; Glover JC; Posthuma D; Djurovic S
- Show more
Grants
- VINNOVA1 October 2021 - 30 September 2026Purpose and goal: There are three main aims of IndiCell: 1)Develop iPS cell-based therapy for two model project, Parkinson’s disease and Macular degeneration 2)Create a development pipeline for iPS cell therapies that includes state-of-the-art workflows addressing generic processes, competence and quality controls 3)Become an important global actor within stem cell therapies Expected results and effects: Development of precision medicine with iPS cell therapy for Parkinson’s disease and Macula degeneration. Increase the speed and number of translations of stem cell therapies from pre-clinical transplantations to patients and identify innovation potential in techniques, processes, devices and knowledge. Put Sweden on the global map of stem cell therapies. Increase the awareness of stem cell therapies among the public. Approach and implementation: IndiCell will be executed by implementation of 6 workpackage where 4 will address the process from donation of cells for reprogramming, enter into a specialized GMP facility via production of iPS cells, therapeutic cells, sorting of cells, quality testing of cellular products and then exit of cells from GMP to bedside and local washing and preparation of cells for transplantation to the patient. 2 work packages which deal with monitoring, defining and creating innovations and one dealing with the project management and actively prepare for the future after the Vinnova funding.
- Swedish Cancer Society1 January 2021My research group builds cellular models of the human brain using the Nobel Prize-winning reprogramming technique. This technology makes it possible to take a skin cell from a person and then in the lab direct the cell backwards in development to become like an embryonic stem cell. In order to build as similar a model as possible of the human brain, we then use growth factors to direct the stem cells so that they form three-dimensional mini-brains known as organoids. These organoids contain structures and cell types found in the real brain, such as cerebral cortex structure, nerve cells, supporting tissue cells, and neural stem cells. To study how cancer cells build up a brain tumor, it is common for researchers to transplant cancer cells from human tumors into the mouse brain and then follow how the tumor grows and also study how different drugs treat the growth. These are important experiments that in the future may result in new treatments and medicines, the questions I ask in this research project are whether there are alternative methods to these experiments and whether the development of organoids as a model could mimic the animal brain. We plan to create organoids that correspond to the "right" part of the brain to study glioblastoma and medulloblastoma. The goal of this project is to develop and use organoids to replace part of the studies where the researchers transplant tumor cells into animal brains to study tumor growth. We hope to achieve two goals, first to develop these models so that they become useful and thus reduce time, costs and animals. The second goal is to use the organoid models we developed to study medulloblastoma and glioblastoma growth in collaboration with research groups who are experts in cancer research. We expect to answer questions about how important the environment, 3D organization, intrinsic genetic and epigenetic mechanisms are for tumor growth.
- Swedish Research Council1 January 2020 - 31 December 2022
- Swedish Research Council1 December 2017 - 31 December 2019
- Knut and Alice Wallenberg Foundation1 January 2013 - 1 January 2018
- Swedish Research Council1 August 2010 - 31 July 2011
Employments
- Principal Researcher, Department of Neuroscience, Karolinska Institutet, 2022-
Degrees and Education
- Docent, Karolinska Institutet, 2014
- Doctor Of Philosophy, Department of Cell and Molecular Biology, Karolinska Institutet, 2006